NASDAQ:ASTH - Nasdaq - US03763A2078 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to ASTH. ASTH was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of ASTH get a neutral evaluation. Nothing too spectacular is happening here. ASTH is not priced too expensively while it is growing strongly. Keep and eye on this one!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.18% | ||
ROE | 6.05% | ||
ROIC | 5.7% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 4.39% | ||
PM (TTM) | 2.12% | ||
GM | 13.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.6 | ||
Debt/FCF | 9.87 | ||
Altman-Z | 3.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.75 | ||
Quick Ratio | 1.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 33.99 | ||
Fwd PE | 15.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 31.06 | ||
EV/EBITDA | 13.26 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
24.47
-0.72 (-2.86%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 33.99 | ||
Fwd PE | 15.03 | ||
P/S | 0.67 | ||
P/FCF | 31.06 | ||
P/OCF | 26.29 | ||
P/B | 1.93 | ||
P/tB | 7.83 | ||
EV/EBITDA | 13.26 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.18% | ||
ROE | 6.05% | ||
ROCE | 9.03% | ||
ROIC | 5.7% | ||
ROICexc | 8.07% | ||
ROICexgc | 35.01% | ||
OM | 4.39% | ||
PM (TTM) | 2.12% | ||
GM | 13.34% | ||
FCFM | 2.17% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.6 | ||
Debt/FCF | 9.87 | ||
Debt/EBITDA | 3.63 | ||
Cap/Depr | 28.76% | ||
Cap/Sales | 0.39% | ||
Interest Coverage | 2.94 | ||
Cash Conversion | 44.51% | ||
Profit Quality | 102.36% | ||
Current Ratio | 1.75 | ||
Quick Ratio | 1.75 | ||
Altman-Z | 3.58 |